Skip to content
Home/Companies/Pharma/4TEEN4 Pharmaceuticals GmbH
4TEEN4 Pharmaceuticals GmbH

4TEEN4 Pharmaceuticals GmbH

Pharma·Germany·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns 4TEEN4 Pharmaceuticals GmbH?

4TEEN4 Pharmaceuticals GmbH is currently owned by Brandenburg Kapital through Fruehphasen- und Wachstumsfonds Brandenburg (2016 vintage), since 2019.

Hand-verified · updated 2026-07-07

Brandenburg Kapital
Investor
Brandenburg Kapital
Fruehphasen- und Wachstumsfonds Brandenburg · 2016 · VC

Key facts

HQGermany
SectorPharma
StatusActive
Website4teen4.de

More from Fruehphasen- und Wachstumsfonds Brandenburg

Other portfolio companies in the same fund.

CrewLinQ GmbH
CrewLinQ GmbH
Active
SaaSGermany· 2023
DearEmployee GmbH
DearEmployee GmbH
Active
SaaSGermany· 2023
DOCFLIX GmbH
Active
HealthTechGermany· 2023
Green Fusion GmbH
Green Fusion GmbH
Active
EnergyGermany· 2023
Mama health technologies GmbH
Active
HealthTechGermany· 2023
Seqstant GmbH
Seqstant GmbH
Active
HealthTechGermany· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track 4TEEN4 Pharmaceuticals GmbH

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy 4TEEN4 Pharmaceuticals GmbH?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on 4TEEN4 Pharmaceuticals GmbH.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue